This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Achillion Pharmaceuticals Inc (ACHN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 33.46M 18.53M 16.11M 25.37M
Receivables 1.78M 277.00K 103.00K 246.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 371.00K 0.00 0.00 0.00
Total Current Assets 124.78M 67.87M 55.09M 57.50M
Property, Plant & Equipment, Gross 6.70M 6.58M 6.48M 6.37M
Accumulated Depreciation & Depletion 5.44M 5.33M 5.49M 5.90M
Property, Plant & Equipment, Net 1.26M 1.25M 994.00K 468.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 36.37M 12.42M 26.54M 269.00K
Total Non-Current Assets 37.64M 13.66M 27.54M 737.00K
Liabilities & Shareholder Equity
Total Assets 162.42M 81.53M 82.63M 58.24M
Accounts Payable 4.59M 4.28M 4.80M 2.67M
Short Term Debt 291.00K 350.00K 141.00K 469.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 9.40M 9.14M 8.94M 5.20M
Long Term Debt 56.00K 347.00K 229.00K 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 2.49M 2.49M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 56.00K 347.00K 2.72M 2.49M
Total Liabilities 9.46M 9.48M 11.66M 7.69M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 152.96M 72.05M 70.97M 50.54M
Common Par 97.00K 80.00K 70.00K 58.00K
Additional Paid In Capital 534.53M 394.68M 346.52M 281.88M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -381.67M -322.73M -275.60M -231.39M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 6.00K 19.00K -20.00K 2.00K
Total Capitalization 153.01M 72.39M 71.20M 50.54M
Total Equity 152.96M 72.05M 70.97M 50.54M
Total Liabilities & Stock Equity 162.42M 81.53M 82.63M 58.24M
Total Common Shares Outstanding 96.79M 79.63M 69.79M 58.38M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 93.98M 73.96M 64.25M 45.08M
Diluted Weighted Shares Outstanding 93.98M 73.96M 64.25M 45.08M
Number of Employees 61 56 48 42
Number of Part-Time Employees 1 1 2 2
ACHN News

ACHN Achillion Pharmaceuticals Inc

Analysts Ratings for ACHN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 6 3 3
Moderate Buy 0 0 0 0
Hold 4 4 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACHN ANALYST REPORT

Brokerage Partners

ACHN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs